-
Safe DNA Gel Stain: Practical Gel Workflow
2026-09-10
Safe DNA Gel Stain (SKU A8743) provides green-fluorescent visualization of DNA and RNA in agarose or acrylamide gels while supporting blue-light imaging as an alternative to routine UV exposure. This guide covers dilution, staining, imaging, and quality control, while noting reduced performance for 100–200 bp fragments and the product’s research-use-only status.
-
HIF-1–tiRNA-Lys Protects Against Renal Ferroptosis
2026-09-10
The reference study identifies HIF-1-induced tiRNA-Lys-CTT-003 as a protective regulator of cisplatin-associated acute kidney injury. Its experiments connect this tRNA-derived small RNA with GRSF1 stabilization and GPX4 upregulation, providing a mechanistic explanation for reduced ferroptosis in renal tubular cells.
-
Phenylmethanesulfonyl fluoride (PMSF) in Cell Assays
2026-09-09
This scenario-driven guide explains where Phenylmethanesulfonyl fluoride (PMSF), SKU A2587, strengthens protein-preservation workflows around viability, proliferation, cytotoxicity, and Western blot experiments. It distinguishes valid post-assay protease control from unsupported claims about direct effects on live-cell viability.
-
GABRE and Magnetic Stimulation in Schizophrenia Models
2026-09-09
The reference study identifies the GABAA receptor ε subunit, encoded by Gabre, as a region-specific mediator of schizophrenia-like behaviors in mice. By combining targeted magnetic stimulation with genetic loss- and gain-of-function experiments, the authors connect left prelimbic cortex GABRE reduction to synaptic rescue and implicate p62/SQSTM1–GABARAP regulation in the response.
-
Sulfo-Cy5 NHS Ester for Immune Cell Imaging
2026-09-08
Sulfo-Cy5 NHS ester enables far-red, aqueous-phase labeling of amine-containing proteins and ligands without relying on organic co-solvents. This workflow guide connects protein conjugation, VLA-4 imaging, and dendritic-cell uptake assays to the immune-remodeling findings of a recent nanostructure study.
-
Cy5 Readouts for Ferritin Vaccine Translation
2026-09-08
Ferritin-based combination vaccines illustrate how multivalent antigen display can strengthen preclinical immune responses. This thought-leadership article explains how a Cy5-conjugated secondary antibody can improve the analytical path from mouse IgG detection to more reproducible translational decisions.
-
Zosuquidar (LY335979): P-gp MDR Modulator
2026-09-07
Zosuquidar, also called LY335979, is a selective P-glycoprotein modulator studied for reversing transporter-mediated multidrug resistance in cancer. Its strongest use case is controlled preclinical sensitization of P-gp-expressing cells, while clinical benefit depends on tumor biology, chemotherapy selection, and pharmacokinetic monitoring.
-
CXCR4 Theranostics in Lymphoma: Imaging to Therapy
2026-09-05
The 2026 review by Dhamecha and colleagues explains how CXCR4-targeted peptides, small molecules, antibodies, and radioligand therapies can connect lymphoma imaging with precision treatment. Its main practical contribution is a receptor-centered framework for patient stratification, tumor localization, therapeutic selection, and response assessment, while emphasizing physiological off-target uptake and CXCR7 compensation as major translational barriers.
-
Sex Differences in Angiotensin II Hypertension
2026-09-05
The reference study used radiotelemetry in conscious, freely moving mice to show that chronic angiotensin II produces a much larger blood-pressure increase in males than females, with gonadectomy reversing the direction of this protection. Its combination of sex-hormone manipulation, baroreflex testing, and autonomic blockade provides a useful framework for separating vascular, reflex, and sympathetic contributions to hypertension.
-
Arachidonic Acid Assay Workflows for Inflammation
2026-09-04
Build more reproducible inflammation, eicosanoid, and blood-brain barrier assays with a controlled arachidonate workflow. This guide combines concentration, vehicle, temperature, and lipid-capture controls with a careful translation of selective hypothermic albumin perfusion research.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-04
Hydroxychloroquine Sulfate (SKU B4874) provides a water-compatible research reagent for studying autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is suited to freshly prepared aqueous workflows, but should not be selected for protocols requiring DMSO or ethanol solubility or prolonged storage of prepared solutions.
-
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-03
S Tag Peptide (SKU A6007) provides a small, highly soluble peptide sequence for recombinant protein detection, antibody-based capture, and protein solubility improvement when genetically fused to a target. It should not be treated as an independently active RNase fragment, and its insolubility in ethanol makes ethanol-based formulation or processing unsuitable.
-
Captopril and Bradykinin: Designing Better Assays
2026-09-03
Captopril is an ACE inhibitor whose effects can be interpreted more rigorously by separating angiotensin, bradykinin, and tissue-level readouts. This article translates guinea pig ileum pharmacology into practical assay logic for hypertension research and carefully bounded oncology studies.
-
ML216: BLM Helicase Inhibition Beyond WRN Models
2026-09-02
Explore ML216, a BLM helicase inhibitor, as a mechanistic probe for DNA repair vulnerabilities, sister chromatid exchange, and cancer-cell dependency. This guide connects BLM biology with the WRN–p53/PUMA findings in MSI colorectal cancer while emphasizing target deconvolution and assay design.
-
ω-Agatoxin IVA Suppresses Seizures in Rats
2026-09-02
This Molecular Neurobiology study identifies selective Cav2.1 blockade by ω-agatoxin IVA as a way to suppress pentylenetetrazole-induced epileptogenesis while preserving tested motor functions. Its combined EEG, behavioral, and immunohistochemical design links reduced seizure activity with increased BDNF and decreased cleaved caspase-3 expression, providing a mechanistic basis for further epilepsy research.